The current use of botulinum toxin

被引:84
作者
Mahant, N [1 ]
Clouston, PD [1 ]
Lorentz, IT [1 ]
机构
[1] Westmead Hosp, Dept Neurol, Westmead, NSW 2145, Australia
关键词
botulinum toxins; dystonia; spasticity; immunoresistance;
D O I
10.1054/jocn.2000.0684
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Botulinum toxin is the most potent neurotoxin known, and has been in clinical use since the late 1970s. The toxin inhibits the release of acetylcholine from nerve terminals by inhibiting transport of the synaptic vesicles, thus causing functional denervation lasting up to 6 months. Our understanding of the mechanism of action of the toxin and the spectrum of diseases treatable with this agent continues to increase. Efficacy has been demonstrated in hemifacial spasm, dystonia, spasticity, hyperhidrosis and other conditions. Alternative serotypes are used in some centres, generally after the development of immunoresisiance to the standard toxin (serotype A), and are likely to be in routine use in the near future. This paper reviews the history, pharmacology and current uses of botulinum toxin. (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:389 / 394
页数:6
相关论文
共 123 条
[1]
Albany K, 1997, MUSCLE NERVE, pS221
[2]
ALDRICH MS, 1999, NEUROBASE
[3]
Laparoscopic Heller's myotomy or botulinum toxin injection for management of esophageal achalasia - Patient choice and treatment outcomes [J].
Andrews, CN ;
Anvari, M ;
Dobranowski, J .
SURGICAL ENDOSCOPY-ULTRASOUND AND INTERVENTIONAL TECHNIQUES, 1999, 13 (08) :742-746
[4]
PRETARSAL APPLICATION OF BOTULINUM TOXIN FOR TREATMENT OF BLEPHAROSPASM [J].
ARAMIDEH, M ;
DEVISSER, BWO ;
BRANS, JWM ;
KOELMAN, JHTM ;
SPEELMAN, JD .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (03) :309-311
[5]
MOTOR PERSISTENCE OF ORBICULARIS OCULI MUSCLE IN EYELID-OPENING DISORDERS [J].
ARAMIDEH, M ;
DEVISSER, BWO ;
KOELMAN, JHTM ;
SPEELMAN, JD .
NEUROLOGY, 1995, 45 (05) :897-902
[6]
BOTULINUM TOXIN TREATMENT IN PATIENTS WITH FOCAL DYSTONIA AND HEMIFACIAL SPASM - A MULTICENTER STUDY OF THE ITALIAN-MOVEMENT-DISORDER-GROUP [J].
BERARDELLI, A ;
FORMICA, A ;
MERCURI, B ;
ABBRUZZESE, G ;
AGNOLI, A ;
AGOSTINO, R ;
CARACENI, T ;
CARELLA, F ;
DEFAZIO, G ;
DEGRANDIS, D ;
ELEOPRA, R ;
GIRLANDA, P ;
LEPORE, V ;
MESSINA, C ;
MILONE, S ;
PRIORI, A ;
STOCCHI, F ;
TUGNOLI, V ;
MANFREDI, M .
ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1993, 14 (05) :361-367
[7]
The pathophysiology of primary dystonia [J].
Berardelli, A ;
Rothwell, JC ;
Hallett, M ;
Thompson, PD ;
Manfredi, M ;
Marsden, CD .
BRAIN, 1998, 121 :1195-1212
[8]
BOTULINUM TOXIN INJECTION FOR THE TREATMENT OF OROMANDIBULAR DYSTONIA [J].
BLITZER, A ;
GREENE, PE ;
BRIN, MF ;
FAHN, S .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1989, 98 (02) :93-97
[9]
Myasthenic crisis after botulinum toxin [J].
Borodic, G .
LANCET, 1998, 352 (9143) :1832-1832
[10]
Botulinum toxin versus trihexyphenidyl in cervical dystoni - A prospective, randomized, double-blind controlled trial [J].
Brans, JWM ;
Lindeboom, R ;
Snoek, JW ;
Zwarts, MJ ;
vanWeerden, TW ;
Brunt, ERP ;
vanHilten, JJ ;
vanderKamp, W ;
Prins, MH ;
Speelman, JD .
NEUROLOGY, 1996, 46 (04) :1066-1072